Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01616017 · ClinicalTrials.gov registry record
Comparison of Cardiac Output Measured by Ultrasound Dilution Method and Pulmonary Artery Thermodilution Technique
A clinical trial, sponsored by Transonic Systems.
- Completed
- Registry status
- 39
- Enrollment target
NCT01616017 is a clinical trial that has completed, run by Transonic Systems. The registered enrollment target is 39 participants.
The verdict
NCT01616017 has completed, sponsored by Transonic Systems.
- COMPLETED
- Registry status
- 39 participants
- Enrollment target
Study Summary
Cardiac output (CO) is an important hemodynamic variable in the management of critically ill patients. The pulmonary artery catheter (PAC) requires invasive techniques with potential complications and there is increasing interest in less invasive methods of measuring CO. This study is designed to compare CO values from PAC thermodilution (COTD) and ultrasound dilution (COUD).
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 39 participants |
| Start Date | 2012-05 |
| Est. Completion | 2013-05 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01616017
The ClinicalTrials.gov registry entry for NCT01616017 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 39 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Transonic Systems, which has 12 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 0 interventions.
NCT01616017 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01616017 about?
NCT01616017 is a clinical study titled "Comparison of Cardiac Output Measured by Ultrasound Dilution Method and Pulmonary Artery Thermodilution Technique". Cardiac output (CO) is an important hemodynamic variable in the management of critically ill patients. The pulmonary artery catheter (PAC) requires invasive techniques with potential complications and there is increasing interest in less invasive methods of measuring CO. This study is designed to co...
What is the current status of trial NCT01616017?
This trial is currently completed. The enrollment target is 39 participants. The study started on 2012-05. Estimated completion is 2013-05.
Who is sponsoring clinical trial NCT01616017?
This trial is sponsored by Transonic Systems, which has 12 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.